S-3304
Term · Oncology and biomedicine · MLC-T-ONC-016611
An orally-agent agent with potential antineoplastic activity. S-3304 inhibits matrix metalloproteinases (MMPs), thereby inducing extracellular matrix degradation, and inhibiting angiogenesis, tumor growth and invasion, and metastasis.
| Identifier | MLC-T-ONC-016611 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016611",
"term": "S-3304",
"field": "Oncology and biomedicine",
"definition": "An orally-agent agent with potential antineoplastic activity. S-3304 inhibits matrix metalloproteinases (MMPs), thereby inducing extracellular matrix degradation, and inhibiting angiogenesis, tumor growth and invasion, and metastasis.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/s-3304/"
}
Record 14,631 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.